Vistin Pharma ASA (OSL:VISTN)

Revenue by Segment

Financials in millions NOK. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Pharmaceuticals	452.29M	429.50M	438.33M	304.85M	278.62M
Pharmaceuticals Growth	5.31%	-2.01%	43.78%	9.41%	9.73%
Total	452.29M	429.50M	438.33M	304.85M	278.62M
Total Growth	5.31%	-2.01%	43.78%	9.41%	9.73%

Revenue by Geography

Financials in millions NOK. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Africa	49.64M	42.91M	65.70M	37.48M	57.93M
Africa Growth	15.70%	-34.69%	75.29%	-35.31%	-6.04%
Europe	358.27M	348.82M	338.87M	195.98M	170.40M
Europe Growth	2.71%	2.94%	72.91%	15.01%	23.16%
Asia	41.05M	32.99M	29.32M	19.80M	23.74M
Asia Growth	24.45%	12.50%	48.11%	-16.59%	20.29%
North and South America	3.33M	4.38M	1.51M	34.42M	23.74M
North and South America Growth	-23.99%	191.10%	-95.63%	44.94%	-28.95%
Total	452.29M	429.09M	435.39M	287.68M	275.81M
Total Growth	5.41%	-1.45%	51.35%	4.30%	8.95%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 15, 2026

Data Sources Report a data error